How to access Rejoyn

Adding Rejoyn to your treatment plan

Rejoyn is only available through your doctor or therapist. If Rejoyn has not been recommended to you, please visit our public site here. You can also check if Rejoyn is available in your area here.

An internet connection is required to download Rejoyn on your smartphone. Rejoyn is available for download from the Apple App Store and the Google Play Store. The app can be found by searching for ‘Rejoyn’.

When you open the Rejoyn app for the first time, you will need to enter an access code.

With your permission, your doctor or therapist will request your access code for you. You will then receive your access code, which may be sent via email or given to you directly by your doctor or therapist.

  • Enter your access code into the app and set a password that is at least eight characters long and includes at least one uppercase letter, one lowercase letter, one number, and one special character. This access code confirms that Rejoyn was recommended to you
  • Verify your email address to activate your account; you can use this email address to reset your Rejoyn password if you forget it
  • Verify your mobile phone number to receive text message reminders from Rejoyn’s text messages

After your email address and mobile phone number are verified, you can begin your treatment. These three verification steps are a one-time process. You will not need to do this again.

Date of preparation: June 2025 | UK-152-2500013 (v1.0)

Intended Use

Rejoyn is a digital therapeutic intended for the treatment of depressive disorder episodes in adults. It is intended to be used alongside usual care and supported by a Healthcare Professional.
Please read the Instructions For Use for Rejoyn.

Adverse Events

Adverse events should be reported. Reporting forms and information can be found at
www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. To report Rejoyn side effects or quality complaints, contact +44 (0) 808 168 6726 or OPUKSafety@otsuka.co.uk


Otsuka

This webpage is for patients interested in or recommended Rejoyn,
an app developed by Otsuka Pharmaceutical Europe Ltd.

Date of preparation: June 2025
UK-152-2500014 (v1.0)

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.